Denali Therapeutics (NasdaqGS:DNLI) FY Conference January 13, 2026 04:30 PM ET Company ParticipantsNone - Company RepresentativeAlex Schuth - Chief Operating and Financial OfficerRyan Watts - CEOPeter Chin - Acting Chief Medical Officer and Head of DevelopmentConference Call ParticipantsJess Fye - Biotech AnalystNone - AnalystJess FyeGreat. Welcome, everyone. Good afternoon. My name's Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing our 44th Annual Healthcare Conference today with Denali. F ...